[Serologic and skin test diagnosis of birch pollen allergy with recombinant Bet v 1, the chief allergen of birch].
BACKGROUND: Type I allergy represents a severe health problem in industrialized countries where up to 20% of the population suffers from allergic rhinitis, conjunctivitis and allergic asthma bronchiale and in severe cases from anaphylaxis, leading to death. OBJECTIVE: The aim of this study was to e...
Հիմնական հեղինակներ: | Menz, G, Dolecek, C, Schönheit-Kenn, U, Ferreira, F, Moser, M, Schneider, T, Suter, M, Boltz-Nitulescu, G, Ebner, C, Kraft, D, Valenta, R |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | German |
Հրապարակվել է: |
1996
|
Նմանատիպ նյութեր
-
Serological and skin-test diagnosis of birch pollen allergy with recombinant Bet v I, the major birch pollen allergen.
: Menz, G, և այլն
Հրապարակվել է: (1996) -
Immunologic characterization of monoclonal antibodies that modulate human IgE binding to the major birch pollen allergen Bet v 1.
: Lebecque, S, և այլն
Հրապարակվել է: (1997) -
High level expression of birch pollen profilin (Bet v 2) in Escherichia coli: purification and characterization of the recombinant allergen.
: Susani, M, և այլն
Հրապարակվել է: (1995) -
The History and Science of the Major Birch Pollen Allergen Bet v 1
: Heimo Breiteneder, և այլն
Հրապարակվել է: (2023-07-01) -
Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1
: Oluwatoyin Akinfenwa, և այլն
Հրապարակվել է: (2021-10-01)